Parkman Healthcare Partners LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2021$7,539,000
-11.5%
60,074
-4.3%
1.65%
-16.6%
Q1 2021$8,514,000
+26.9%
62,780
+19.7%
1.98%
+15.0%
Q4 2020$6,711,000
+19.2%
52,458
+4.9%
1.72%
+15.4%
Q3 2020$5,628,000
+2.7%
50,016
-13.0%
1.49%
-3.4%
Q2 2020$5,478,000
+62.6%
57,500
+53.3%
1.54%
-1.2%
Q1 2020$3,370,00037,5001.56%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders